Implementation of an Infusion Management Scheme to Improve Patient Outcome in Tertiary Children's Hospitals

NCT05152446 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 1000

Last updated 2024-11-04

No results posted yet for this study

Summary

This study is a multi-center before-after trial design. The object is to observe whether the incidence of central line associated blood stream infection(CLABSI) will tend to descend compared with retrospective electronic medical record data after implementation of an infusion management scheme which comes form " Clinical Practice Guideline on Infusion Therapy in Children " .

Conditions

Interventions

OTHER

Infusion management scheme

* To set up a pediatric intravenous infusion team; * To form standardized procedures by carrying out a quality improvement program in collecting and sending samples for inspection once suspected CLABSI occurs (1 month for training and 3 months for continuous improvement ); providing infusion training curriculums to nurses in forms of lectures, group discussions, operation demonstrations, and scenario simulations, holding practice review meeting with them; providing elements to caregivers of educational leaflet, nurse-provided education during patients' infusion therapy( 6-month implementation); * To observe the continued daily infusion practice in 6 months.

Sponsors & Collaborators

  • Xiamen Children's Hospital

    collaborator OTHER
  • Anhui Provincial Children's Hospital

    collaborator OTHER
  • Dalian women and children's medical group

    collaborator UNKNOWN
  • First Affiliated Hospital of Guangxi Medical University

    collaborator OTHER
  • Qidong Women's and Children's Health

    collaborator UNKNOWN
  • Chengdu Women's and Children's Central Hospital

    collaborator OTHER
  • Hunan Children's Hospital

    collaborator OTHER_GOV
  • Tongji Hospital

    collaborator OTHER
  • Children's Hospital of Fudan University

    lead OTHER

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
1 Day
Max Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-07
Primary Completion
2024-11-01
Completion
2024-11-01

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05152446 on ClinicalTrials.gov